Holen Sie sich die Stockscreener-App
3.635
0.41%
-0.015
Schlusskurs vom Vortag:
$3.65
Offen:
$3.61
24-Stunden-Volumen:
7,317
Relative Volume:
0.03
Marktkapitalisierung:
$86.27M
Einnahmen:
$48.20M
Nettoeinkommen (Verlust:
$-35.05M
KGV:
-2.3193
EPS:
-1.5673
Netto-Cashflow:
$-13.02M
1W Leistung:
+5.06%
1M Leistung:
+15.40%
6M Leistung:
+116.37%
1J Leistung:
+14.49%
1-Tages-Spanne:
$3.52
$3.65
1-Wochen-Bereich:
$3.3576
$4.31
52-Wochen-Spanne:
$1.06
$5.22
Celularity Inc Stock (CELU) Company Profile
Firmenname
Celularity Inc
Sektor
Branche
Telefon
(908) 768-2170
Adresse
170 PARK AVE, FLORHAM PARK
Vergleichen Sie CELU mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CELU
Celularity Inc
|
3.602 | 99.39M | 48.20M | -35.05M | -13.02M | -1.5673 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
604.87 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.72 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
667.34 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
310.73 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Celularity Inc Stock (CELU) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-01-30 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-12-22 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-06-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-06 | Herabstufung | Truist | Buy → Hold |
| 2022-01-28 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-24 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Celularity Inc Aktie (CELU) Neueste Nachrichten
Celularity completes balance sheet restructuring, retires $41.6M in debt - MSN
Why Celularity Inc. Equity Warrant stock attracts strong analyst attentionNew Guidance & Risk Controlled Stock Alerts - thegnnews.com
Celularity Sells IP to Celeniv, Reduces Debt - MSN
Tick level data insight on Celularity Inc. volatilityJuly 2025 Recap & Fast Gain Swing Alerts - Newser
Celularity Restructures Debt with Intellectual Property Sale to Celeniv - AInvest
Celularity Completes Balance Sheet Restructuring, Eliminates $41.6 Million in Senior Secured Debt - AInvest
Celularity's Strong Positioning and Financial Restructuring Drive Buy Rating - AInvest
Why Celularity Inc. Equity Warrant is moving todayWeekly Stock Recap & Safe Investment Capital Preservation Plans - Newser
What does recent volatility data suggest for Celularity Inc. Equity WarrantAnalyst Downgrade & Daily Price Action Insights - Newser
Momentum divergence signals in Celularity Inc. chart2025 Historical Comparison & Stepwise Trade Signal Implementation - Newser
Can Celularity Inc. Equity Warrant hit a new high this monthRate Cut & Fast Exit and Entry Trade Guides - Newser
Is a relief rally coming for Celularity Inc. holdersTrade Analysis Report & Daily Volume Surge Signals - Newser
Published on: 2025-08-19 05:57:28 - Newser
What to do if you’re stuck in Celularity Inc. Equity WarrantMarket Growth Report & Weekly Top Gainers Trade List - Newser
Pattern recognition hints at Celularity Inc. Equity Warrant upsideLong Setup & Detailed Earnings Play Alerts - Newser
Can trapped investors hope for a rebound in Celularity Inc.Weekly Stock Recap & Daily Profit Maximizing Tips - Newser
Signal strength of Celularity Inc. stock in tech scannersQuarterly Trade Review & Reliable Entry Point Alerts - Newser
When is the best time to exit Celularity Inc. Equity WarrantQuarterly Earnings Report & Weekly Watchlist for Hot Stocks - Newser
Sentiment analysis tools applied to Celularity Inc.IPO Watch & Trade Opportunity Analysis - Newser
Using Bollinger Bands to evaluate Celularity Inc. Equity WarrantTreasury Yields & AI Powered Market Entry Ideas - Newser
Celularity Inc. Recovery Potential Based on Technical ToolsMarket Risk Report & Verified Short-Term Trading Plans - 선데이타임즈
Bollinger Band Squeeze Points to Volatility in Celularity Inc. Equity WarrantJuly 2025 Outlook & Community Consensus Stock Picks - 선데이타임즈
Is a relief rally coming for Celularity Inc. Equity Warrant holdersBuy Signal & Safe Capital Growth Plans - Newser
Visual trend scoring systems applied to Celularity Inc.Weekly Investment Report & Weekly High Conviction Ideas - Newser
Published on: 2025-08-18 22:55:18 - Newser
Celularity shares rise 3.61% after-hours after completing major balance sheet restructuring. - AInvest
Celularity completes balance sheet restructuring, retires $41.6mln senior secured debt. - AInvest
Celularity Receives New Coverage with Speculative Buy Rating from WBB Securities - AInvest
Celularity: WBB Securities initiates coverage with Speculative Buy, $6 price target. - AInvest
Celularity’s Strategic Positioning and Financial Restructuring Drive Buy Rating - TipRanks
Celularity completes major balance sheet restructuring - MarketScreener
Celularity retires all senior secured debt in restructuring deal By Investing.com - Investing.com Canada
Celularity retires all senior secured debt in restructuring deal - Investing.com
Celularity Completes Major Restructuring, Retires All $41.6 Million in Senior Secured Debt and Monetizes Intellectual Property Assets - AInvest
Celularity Completes Major Balance Sheet Restructuring, Retires All $41.6 Million in Senior Secured Debt - GlobeNewswire
Celularity Eliminates Senior Debt, Restructures, and Licenses Back IP Assets - AInvest
Celularity Inc. Retires All $41.6 Million in Senior Secured Debt - MarketScreener
Applying sector rotation models to Celularity Inc.July 2025 Closing Moves & Fast Entry and Exit Trade Plans - Newser
Celularity Enters Series Seed Stock Agreement with Defeye - MSN
Will Celularity Inc. Equity Warrant stock benefit from AI tech trendsQuarterly Earnings Summary & Long-Term Capital Growth Strategies - Newser
How hedge fund analytics apply to Celularity Inc. Equity Warrant stockQuarterly Earnings Summary & Reliable Momentum Entry Alerts - Newser
What recovery options are there for Celularity Inc. Equity Warrant2025 Retail Activity & Technical Buy Zone Confirmations - Newser
Is it too late to sell Celularity Inc. Equity WarrantQuarterly Market Summary & Reliable Price Action Trade Plans - Newser
Forecasting Celularity Inc. Equity Warrant price range with options dataChart Signals & Risk Managed Investment Signals - Newser
Reversal indicators forming on Celularity Inc. Equity Warrant stockGap Down & Weekly Top Performers Watchlists - Newser
Published on: 2025-08-17 23:09:58 - Newser
Multi asset correlation models including Celularity Inc.Quarterly Portfolio Summary & AI Powered Market Entry Ideas - Newser
How to manage a losing position in Celularity Inc.Market Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
News impact scoring models applied to Celularity Inc.Inflation Watch & Fast Entry Momentum Alerts - Newser
Understanding Celularity Inc. Equity Warrant’s price movementJuly 2025 Breakouts & AI Driven Stock Price Forecasts - Newser
Momentum Traders Eye Celularity Inc. Equity Warrant for Quick Bounce2025 Volatility Report & Precise Buy Zone Identification - sundaytimes.kr
Finanzdaten der Celularity Inc-Aktie (CELU)
Umsatz
Nettogewinn
Free Cashflow
ENV
Celularity Inc-Aktie (CELU) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Hariri Robert J | Chief Executive Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
3,281 |
0 |
21,482 |
| Haines John R | Senior Exec Vice President |
Apr 13 '25 |
Option Exercise |
0.00 |
1,641 |
0 |
29,698 |
| Beers David C | Chief Financial Officer |
Apr 13 '25 |
Option Exercise |
0.00 |
1,025 |
0 |
18,561 |
| Brigido Stephen | Pres., Functional Regeneration |
Feb 17 '25 |
Option Exercise |
0.00 |
10,000 |
0 |
11,641 |
| Beers David C | Chief Financial Officer |
Feb 17 '25 |
Option Exercise |
0.00 |
12,500 |
0 |
21,932 |
| Haines John R | Senior Exec Vice President |
Feb 17 '25 |
Option Exercise |
0.00 |
20,000 |
0 |
35,092 |
0.88%
0.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):